www.vitastock.com vitaminssupplementsnutrition products
Home Contact Us Site map Health Articles Whole Health

Cholest-Action - Cholesterol health products

Cholest-Action from Action Labs - features a patent-pending black tea extract that provides a guaranteed 22.5% concentration of theavlavins. Theaflavins are concentrated through a proprietary oxidation and extraction process of green tea. This process converts green tea into black tea which increases the active constituent, theaflavins. Cholest-ACTION supplement is intended to provide nutritive support for normal cardiovascular health.

Buy Cholest-Action online
Available Quantity Price Buy
EVitamins 25 Softgels
EVitamins 50 Softgels

Buying Cholest-Action online is convenient and easy. You don't have to visit your local drugstore to buy Cholest-Action. From the comfort of your home you can learn how to take Cholest-Action, what are its ingridients, how it interacts with medications. Money-wise it is easier to find wholesale Cholest-Action or Internet store offering discounts on Cholest-Action. Just search for this phrases on some major search engine. You can choose the price by comparing our price with prices of other Internet stores offering discount Cholest-Action. So feel free to read, learn, research and buy Cholest-Action online.

How to take:
Take one softgel daily with a meal or glass of water.

Precautions:
This product contains approximately 15 mg of naturally occuring caffeine per serving. Keep out of the reach of children.

Ingredients:
Black Tea Extract (Supplying 84 mg [22.5%] Theaflavins) 375 mg

Other Ingredients Soybean Oil, Gelatin Softgel (gelatin, sorbitol, glycerin, caramel color, opaquing agent), Lecithin, Yellow Beeswax and Mixed Tocopherol Concentrate

 

Back To Cholesterol Category

Action Labs Manufacturer Website

Cholesterol - Cholest-Action

Brand: Action Labs





Home | Contact Us | Site map | Health Links

Copyright © 2004-2006 VitaStock.com. All rights reserved.
Products mentioned are trademarks of their respective companies.

October 12, 2008